Alzheimer's Disease – FDA Research on Ethnicity and Gender Differences

Alzheimer's Disease – FDA Research on Ethnicity and Gender Differences

Watch the webcast on www.fda.gov

NCTR scientists, Drs. Sherry Ferguson and Vijayalakshmi Varma, presented a webcast lecture titled “Ethnicity- and Gender-Related Differences in Alzheimer’s Disease” as part of the FDA Grand Rounds series. Alzheimer’s Disease (AD) has a higher incidence in women at later ages and poses a greater threat to African American and Hispanic communities. This presentation discussed NCTR’s novel research into proteins implicated in AD and their levels in post-mortem African-American and Caucasian brain tissues from both genders to explore ethnicity- and gender-related differences. Research studies such as these are crucial to a precision-medicine approach to treating neurodegenerative diseases like AD.

For more information please contact Sherry Ferguson, Ph.D., Acting Director, Division of Neurotoxicology, FDA/NCTR orVijayalakshmi Varma, Ph.D., Division of Systems Biology, FDA/NCTR or watch the webcast on www.FDA.gov.